These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7515931)

  • 21. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
    Laman JD; Schellekens MM; Lewis GK; Moore JP; Matthews TJ; Langedijk JP; Meloen RH; Boersma WJ; Claassen E
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):605-12. PubMed ID: 8369165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120.
    Karwowska S; Gorny MK; Buchbinder A; Gianakakos V; Williams C; Fuerst T; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1099-106. PubMed ID: 1380257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.
    Matsushita S; Matsumi S; Yoshimura K; Morikita T; Murakami T; Takatsuki K
    J Virol; 1995 Jun; 69(6):3333-40. PubMed ID: 7538171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assessment of masking of neutralization epitopes in HIV-1.
    Agarwal A; Hioe CE; Swetnam J; Zolla-Pazner S; Cardozo T
    Vaccine; 2011 Sep; 29(39):6736-41. PubMed ID: 21216319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120.
    Ohno T; Terada M; Yoneda Y; Shea KW; Chambers RF; Stroka DM; Nakamura M; Kufe DW
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10726-9. PubMed ID: 1961739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization.
    White-Scharf ME; Potts BJ; Smith LM; Sokolowski KA; Rusche JR; Silver S
    Virology; 1993 Jan; 192(1):197-206. PubMed ID: 7685962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1.
    Kliks SC; Shioda T; Haigwood NL; Levy JA
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11518-22. PubMed ID: 7505441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
    Huisman JG; Carotenuto A; Labrijn AF; Papavoine CH; Laman JD; Schellekens MM; Koppelman MH; Hilbers CW
    Biochemistry; 2000 Sep; 39(35):10866-76. PubMed ID: 10978173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal analysis of human anti-V3 monoclonal antibodies selected by a V3 tetramer.
    Li L; Wang XH; Banerjee S; Volsky B; Williams C; Moody MA; Zolla-Pazner S; Gorny MK
    Hum Antibodies; 2012; 21(3-4):65-73. PubMed ID: 23549023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.
    Scott CF; Silver S; Profy AT; Putney SD; Langlois A; Weinhold K; Robinson JE
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8597-601. PubMed ID: 1700435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.
    Posner MR; Cavacini LA; Emes CL; Power J; Byrn R
    J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):7-14. PubMed ID: 8417177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reactivity of monoclonal antibodies to a chimeric V3 peptide of HIV-1 with peptide analogues studied by biosensor technology and ELISA.
    Richalet-Sécordel PM; Zeder-Lutz G; Plaue S; Sommermeyer-Leroux G; Van Regenmortel MH
    J Immunol Methods; 1994 Dec; 176(2):221-34. PubMed ID: 7983380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, expression, and characterization of a multivalent, combination HIV microbicide.
    Sexton A; Harman S; Shattock RJ; Ma JK
    FASEB J; 2009 Oct; 23(10):3590-600. PubMed ID: 19470798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of HIV-1 gp120 to an anti-V3 loop antibody reveals novel antigen-induced epitopes.
    Denisova G; Zwickel J; Gershoni JM
    FASEB J; 1995 Jan; 9(1):127-32. PubMed ID: 7529735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope analysis using kinetic measurements of antibody binding to synthetic peptides presenting single amino acid substitutions.
    Zeder-Lutz G; Altschuh D; Denery-Papini S; Briand JP; Tribbick G; Van Regenmortel MH
    J Mol Recognit; 1993 Jun; 6(2):71-9. PubMed ID: 7508237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators.
    D'Souza MP; Durda P; Hanson CV; Milman G
    AIDS; 1991 Sep; 5(9):1061-70. PubMed ID: 1718320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of a 17-amino acid residue, virus-neutralizing microantibody.
    Heap CJ; Wang Y; Pinheiro TJT; Reading SA; Jennings KR; Dimmock NJ
    J Gen Virol; 2005 Jun; 86(Pt 6):1791-1800. PubMed ID: 15914858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of multivalent anionic porphyrins to V3 loop fragments of an HIV-1 envelope and their antiviral activity.
    Watanabe K; Negi S; Sugiura Y; Kiriyama A; Honbo A; Iga K; Kodama EN; Naitoh T; Matsuoka M; Kano K
    Chem Asian J; 2010 Apr; 5(4):825-34. PubMed ID: 20112333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus.
    de Lorimier R; Moody MA; Haynes BF; Spicer LD
    Biochemistry; 1994 Mar; 33(8):2055-62. PubMed ID: 7509632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8.
    Vella C; Smith MH; Farrar GH; Jones DH; Daniels RS
    Vaccine; 1995; 13(8):735-41. PubMed ID: 7483788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.